We are a blank check company incorporated on October 29, 2025 as a Cayman Islands exempted company for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Due to our management team’s significant success in the chemical and healthcare sectors, we believe we are in a unique position to take advantage of the robust pipeline of high quality SPAC merger partners. We have identified the following general criteria and guidelines that we believe are important in evaluating prospective targets. We will use these criteria and guidelines in evaluating acquisition opportunities, but we may decide to enter into our initial business combination with a target business that does not meet these criteria and guidelines. 1) Target Business Size. 2) Proven Unit Economics and Growing Companies. 3) Competitive Position. 4) Capable Management Team. 5) Benefit from Being a Public Company. 6) Defensible Business Niche. 7) Potential for Stable Free Cash Flow. These criteria are not intended to be exhaustive. Any evaluation relating to the merits of a particular initial business combination may be based, to the extent relevant, on these general guidelines as well as other considerations, factors and criteria that our management may deem relevant.